Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,341,000 | 1,590,000 | 191,000 | 739,000 | 942,000 |
| Marketable Securities | 5,883,000 | 4,402,000 | 3,589,000 | 3,703,000 | 3,966,000 |
| Receivables | 5,411,000 | 5,341,000 | 3,882,000 | 3,864,000 | 3,618,000 |
| Inventories | 2,723,000 | 2,597,000 | 1,614,000 | 1,654,000 | 1,638,000 |
| Other current assets | 1,810,000 | 1,886,000 | 1,157,000 | 1,231,000 | 1,320,000 |
| TOTAL | $17,168,000 | $15,816,000 | $10,433,000 | $11,191,000 | $11,484,000 |
| Non-Current Assets | |||||
| PPE Net | 14,014,000 | 13,745,000 | 8,218,000 | N/A | 7,667,000 |
| Investments And Advances | 2,646,000 | 2,183,000 | 1,917,000 | 1,721,000 | 1,541,000 |
| Other Non-Current Assets | 4,496,000 | 5,020,000 | 2,409,000 | 2,319,000 | 2,155,000 |
| TOTAL | $21,156,000 | $20,948,000 | $12,544,000 | $4,040,000 | $11,363,000 |
| Total Assets | $33,488,000 | $32,044,000 | $20,225,000 | $20,574,000 | $20,239,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,417,000 | 1,440,000 | 855,000 | 951,000 | 694,000 |
| Accrued Expenses | 917,000 | 850,000 | 567,000 | 669,000 | 576,000 |
| Other current liabilities | 3,179,000 | 3,549,000 | 1,340,000 | 1,695,000 | 1,427,000 |
| TOTAL | $12,344,000 | $12,218,000 | $7,478,000 | $9,185,000 | $9,092,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,257,000 | 1,266,000 | 524,000 | 525,000 | 525,000 |
| Other Non-Current Liabilities | 3,137,000 | 3,054,000 | 1,637,000 | 1,676,000 | 1,564,000 |
| TOTAL | $4,972,000 | $4,853,000 | $2,559,000 | $2,502,000 | $2,361,000 |
| Total Liabilities | $17,316,000 | $17,071,000 | $10,037,000 | $11,687,000 | $11,453,000 |
| Shareholders' Equity | |||||
| Common Shares | 336,000 | 335,000 | 213,000 | 213,000 | 212,000 |
| Retained earnings | 19,453,000 | 18,085,000 | 14,577,000 | 13,396,000 | 13,085,000 |
| Other shareholders' equity | -4,604,000 | -4,876,000 | -3,418,000 | -3,287,000 | -3,868,000 |
| TOTAL | $16,172,000 | $14,973,000 | $10,188,000 | $8,887,000 | $8,786,000 |
| Total Liabilities And Equity | $33,488,000 | $32,044,000 | $20,225,000 | $20,574,000 | $20,239,000 |